ALS Therapy Development Institute:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:ALS Therapy Development Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11472
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ALS Therapy Development Institute (ALS TDI), formerly ALS Therapy Development Foundation, is a drug discovery center that offers research and healthcare services. The center’s pipeline product include AT-1501, a novel antibody therapeutic that blocks specific immune cell activation and protects nerves against the progression of ALS and alzheimer’s disease. It offers diagnostic services such as electromyography, nerve conduction studies, magnetic resonance imaging, genetic tests, muscle biopsy, spinal tap, blood and urine tests. ALS TDI collaborates with other biotech and research companies to develop new drugs. The center undertakes clinical trials for various drugs. ALS TDI is headquartered in Cambridge, Massachusetts, the US.

ALS Therapy Development Institute – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ALS Therapy Development Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ALS Therapy Development Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ALS Therapy Development Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ALS Therapy Development Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
ALS Therapy Development Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
ALS Therapy Development Institute, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Anelixis Therapeutics Raises USD2.6 Million in Venture Financing 10
Anelixis Therapeutics Raises USD4.3 Million in Venture Financing 11
Partnerships 12
Denali Therapeutics Enters into Research Agreement with ALS Therapy Development Institute 12
Chaperone Therapeutics Enters into Agreement with ALS Therapy Development Institute 13
ALS TDI and Anelixis Therapeutics Enters into Research Agreement with Neurimmune 14
ALS Therapy Development Institute Enters into Research Agreement with Anida Pharma 15
ALS Therapy Enters Into Research Agreement With Gladstone For ALS Treatments 16
ALS Therapy Development Institute Enters Into Co-Development Agreement With Neurotune 17
ALS Therapy Development Institute Enters Into Co-Development Agreement With Regenesance For ALS 18
ALS Therapy Development Institute – Key Competitors 20
ALS Therapy Development Institute – Key Employees 21
ALS Therapy Development Institute – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
ALS Therapy Development Institute, Pharmaceuticals & Healthcare, Key Facts 2
ALS Therapy Development Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ALS Therapy Development Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ALS Therapy Development Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ALS Therapy Development Institute, Deals By Therapy Area, 2012 to YTD 2018 8
ALS Therapy Development Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Anelixis Therapeutics Raises USD2.6 Million in Venture Financing 10
Anelixis Therapeutics Raises USD4.3 Million in Venture Financing 11
Denali Therapeutics Enters into Research Agreement with ALS Therapy Development Institute 12
Chaperone Therapeutics Enters into Agreement with ALS Therapy Development Institute 13
ALS TDI and Anelixis Therapeutics Enters into Research Agreement with Neurimmune 14
ALS Therapy Development Institute Enters into Research Agreement with Anida Pharma 15
ALS Therapy Enters Into Research Agreement With Gladstone For ALS Treatments 16
ALS Therapy Development Institute Enters Into Co-Development Agreement With Neurotune 17
ALS Therapy Development Institute Enters Into Co-Development Agreement With Regenesance For ALS 18
ALS Therapy Development Institute, Key Competitors 20
ALS Therapy Development Institute, Key Employees 21
ALS Therapy Development Institute, Subsidiaries 23

List of Figures
ALS Therapy Development Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
ALS Therapy Development Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
ALS Therapy Development Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
ALS Therapy Development Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
ALS Therapy Development Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ALS Therapy Development Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
ALS Therapy Development Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ALS Therapy Development Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[ALS Therapy Development Institute:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Egdon Resources Plc (EDR):企業の財務・戦略的SWOT分析
    Summary Egdon Resources Plc (Egdon) is oil and gas company that offers exploration and production services. The company explores and develops petroleum and natural gas assets in East Midlands, North East England, North West England, and Southern England, the UK. Its project site includes Wressle, No …
  • Warba Insurance Company – K.S.C.P:企業の戦略・SWOT・財務情報
    Warba Insurance Company - K.S.C.P - Strategy, SWOT and Corporate Finance Report Summary Warba Insurance Company - K.S.C.P - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • FBD Holdings Plc (EG7):企業の財務・戦略的SWOT分析
    FBD Holdings Plc (EG7) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • N Brown Group plc:企業の戦略・SWOT・財務情報
    N Brown Group plc - Strategy, SWOT and Corporate Finance Report Summary N Brown Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • NuSirt Biopharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary NuSirt Biopharma Inc (NuSirt Sciences) develops a technology platform that combines natural compounds with various pharmaceutical agents to prevent and treat chronic diseases resulting from over-nutrition and aging. Its technology platform focuses on activating sirtuin pathways through the a …
  • Nanosonics Ltd (NAN):企業の財務・戦略的SWOT分析
    Nanosonics Ltd (NAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Orsted AS (ORSTED):石油・ガス:M&Aディール及び事業提携情報
    Summary Orsted AS (Orsted) formerly Dong Energy A/S, is an integrated energy company that procures, produces, distributes and trades energy and energy related products. It generates electricity and heat using conventional fuel and wind energy sources. The company also develops, constructs, owns and …
  • Arma Global Corporation:企業の戦略・SWOT・財務情報
    Arma Global Corporation - Strategy, SWOT and Corporate Finance Report Summary Arma Global Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • SONIFI Solutions, Inc:企業の戦略的SWOT分析
    SONIFI Solutions, Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Catalyst Biosciences Inc:企業のM&A・事業提携・投資動向
    Catalyst Biosciences Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Catalyst Biosciences Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • SunPower Corporation (SPWR)-エネルギー分野:企業M&A・提携分析
    Summary SunPower Corporation (SunPower), a subsidiary of Total Energies Nouvelles Activites USA, is a provider of solar technology and energy services. The company has a presence in solar value chain from cell and panel manufacturing, project development, project finance through engineering, procure …
  • OncoSec Medical Inc (ONCS)-医療機器分野:企業M&A・提携分析
    Summary OncoSec Medical Inc (OncoSec) is a biotechnology company that offers services to stimulate body’s immune system and attack cancer. It’s lead candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through i …
  • Proofpoint Inc (PFPT):企業の財務・戦略的SWOT分析
    Proofpoint Inc (PFPT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Torrent Pharmaceuticals Ltd (TORNTPHARM):製薬・医療:M&Aディール及び事業提携情報
    Summary Torrent Pharmaceuticals Ltd (Torrent) manufactures and markets branded and unbranded generic pharmaceuticals. It provides products in cardiovascular, central nervous system, gastro-intestinal, diabetology, anti-infective and pain management segments. Also, the company has presence in nephrol …
  • Icagen Inc:企業の戦略的SWOT分析
    Icagen Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Kamada Ltd (KMDA):企業の財務・戦略的SWOT分析
    Kamada Ltd (KMDA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Duke Energy Corporation (DUK):電力:M&Aディール及び事業提携情報
    Summary Duke Energy Corporation (Duke Energy) is an integrated energy utility that undertakes the generation, transmission, distribution and sale of electricity; transportation and sale of natural gas; and provision of related energy services in the Southeast and Midwest regions of the US. It also p …
  • Sinolink Worldwide Holdings Ltd:企業の戦略・SWOT・財務情報
    Sinolink Worldwide Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Sinolink Worldwide Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Institute for Translational Vaccinology:製薬・医療:M&Aディール及び事業提携情報
    Summary Institute for Translational Vaccinology (Intravacc) is a nonprofit research and development organization that concentrates on the development of vaccines. The organization’s services include technology transfer, exploratory and clinical research and regulatory support. It also provides novel …
  • Eleison Pharmaceuticals LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Eleison Pharmaceuticals LLC (Eleison Pharmaceuticals) is a drug development company that acquires, develops, and commercializes clinical stage drug candidates for orphan cancers. The company’s pipeline products include glufosfamide and inhaled lipid-complexed cisplatin. Its glufosfamide is a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆